You have 9 free searches left this month | for more free features.

Lorazepam

Showing 1 - 25 of 307

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Trial (LSD (150 µg) + ketanserin (40 mg), LSD (150 µg) + olanzapine (10 mg), LSD (150 µg) + lorazepam (2 mg))

Not yet recruiting
  • Healthy
  • LSD (150 µg) + ketanserin (40 mg)
  • +4 more
  • (no location specified)
Jul 27, 2023

Depression, Anxiety, Fear, Depression Trial in Tulsa (Lorazepam, Placebo)

Not yet recruiting
  • Depression, Anxiety
  • +5 more
  • Lorazepam
  • Placebo
  • Tulsa, Oklahoma
    Laureate Institute for Brain Research
Aug 16, 2023

Premedication for Claustrophobic Patients for MRI Scan

Recruiting
  • Claustrophobia
    • Surrey, British Columbia, Canada
      Salem Anaesthesia Pain Clinic
    May 28, 2023

    Down Syndrome, Regression Trial (Lorazepam, Intravenous immunoglobulin (IVIG), Tofacitinib)

    Not yet recruiting
    • Down Syndrome
    • Regression
    • Lorazepam
    • +2 more
    • (no location specified)
    Dec 14, 2022

    Depression Trial in Shanghai (Mianserin, Lorazepam)

    Not yet recruiting
    • Depression
    • Shanghai, China
      Shanghai Mental Health Center
    Oct 26, 2022

    Schizophrenia Agitation, Schizo Affective Disorder, Bipolar Disorder Trial in Philadelphia (Dexmedetomidine, Lorazepam 2 MG/ML)

    Recruiting
    • Schizophrenia Agitation
    • +3 more
    • Philadelphia, Pennsylvania
      Temple University Episcopal Hospital
    Oct 16, 2023

    Depressive Disorder, Treatment-Resistant Trial in Saint Louis (Ketamine, Clonidine, )

    Completed
    • Depressive Disorder, Treatment-Resistant
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 22, 2022

    Panic Disorder Trial (Hydroxyzine, Escitalopram Oxalate)

    Not yet recruiting
    • Panic Disorder
    • (no location specified)
    Feb 20, 2023

    Low Intensity Focussed Ultrasound Trial in Toronto (Carbamazepine, Lorazepam, Dextromethorphan)

    Recruiting
    • Low Intensity Focussed Ultrasound
    • Toronto, Ontario, Canada
      Toronto Western Hospital
    May 18, 2022

    Pain, Breast Cancer, Lung Cancer Trial in Stanford (Gabapentin, Lorazepam (active control), Placebo (inactive))

    Terminated
    • Pain
    • +2 more
    • Stanford, California
      Stanford University School of Medicine
    May 3, 2022

    Alcohol Withdrawal Syndrome Trial in Rochester (Gabapentin, Benzodiazepines, Divalproex Sodium)

    Completed
    • Alcohol Withdrawal Syndrome
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Mar 1, 2022

    Anticholinergics Toxicity Trial in Aurora (Physostigmine, Lorazepam)

    Completed
    • Anticholinergics Toxicity
    • Aurora, Colorado
      University of Colorado Anschutz Medical Campus, Children's Hospi
    Jul 28, 2021

    Schizophrenia, Bipolar Disorder, Healthy Trial in Ann Arbor (Placebo and fMRI, Lorazepam and fMRI)

    Recruiting
    • Schizophrenia
    • +6 more
    • Placebo and fMRI
    • Lorazepam and fMRI
    • Ann Arbor, Michigan
      University of Michigan
    Mar 4, 2022

    LORA-PITA IV General Investigation

    Recruiting
    • Status Epilepticus
    • Lorazepam
    • Tokyo, Shibuya-ku, Japan
      Pfizer Local Country office
    Sep 21, 2021

    Analgesia Trial (Lorazepam 4 mg/ml)

    Not yet recruiting
    • Analgesia
    • Lorazepam 4 mg/ml
    • (no location specified)
    Nov 20, 2020

    Advanced Cancers Trial in Houston (Lorazepam, Placebo, Haloperidol decanoate)

    Active, not recruiting
    • Advanced Cancers
    • Lorazepam
    • +3 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Oct 8, 2020

    Blood Concentration in Lorazepam and Treatment in Adult

    Recruiting
    • Catatonia
      • Lille, France
        Hôpital Fontan, CHU lille
      Sep 17, 2020

      Hip Surgery, Post Operative Pain Control Trial (Lumbar Plexus Catheter, Lumbar Epidural Catheter, Patient Controlled Analgesia)

      Terminated
      • Hip Surgery
      • Post Operative Pain Control
      • Lumbar Plexus Catheter
      • +10 more
      • (no location specified)
      Oct 4, 2021

      Methamphetamine Intoxication (Disorder) Trial in United States (IXT-m200, Lorazepam, Haloperidol)

      Recruiting
      • Methamphetamine Intoxication (Disorder)
      • IXT-m200
      • +2 more
      • Little Rock, Arkansas
      • +3 more
      Dec 3, 2021

      Epidermolysis Bullosa Trial in Aurora, Chicago, New York (Palifermin, Fludarabine, Busulfan)

      Terminated
      • Epidermolysis Bullosa
      • Aurora, Colorado
      • +2 more
      Aug 13, 2021

      Cardiac Arrest, Anoxic Encephalopathy, Status Epilepticus Trial in Belgium, Netherlands (Anti-epileptic drugs, No anti-epileptic

      Completed
      • Cardiac Arrest
      • +2 more
      • Anti-epileptic drugs
      • No anti-epileptic drugs
      • Brussels, Lenniksebaan 808, Belgium
      • +10 more
      Feb 3, 2022

      Alcohol Withdrawal, Alcohol Withdrawal Delirium Trial in Peoria (Phenobarbital, Lorazepam)

      Recruiting
      • Alcohol Withdrawal
      • Alcohol Withdrawal Delirium
      • Peoria, Illinois
        OSF Saint Francis Medical Center
      Oct 6, 2020

      Oral Sedation and Cervical Dilator Pain Trial in Baltimore (Oxycodone and Lorazepam (Active Comparator), Placebo Comparator)

      Completed
      • Oral Sedation and Cervical Dilator Pain
      • Oxycodone and Lorazepam (Active Comparator)
      • Placebo Comparator
      • Baltimore, Maryland
        Johns Hopkins' Women's Center for Family Planning
      Mar 10, 2020

      Epilepsy Trial in United States (Brivaracetam, Lorazepam)

      Completed
      • Epilepsy
      • Birmingham, Alabama
      • +13 more
      Nov 26, 2020